The ovarian cancer diagnostics therapeutics market is growing as awareness of early detection, biomarker testing, targeted therapies, and personalized oncology care expands. The market was valued at USD 3.26 billion in 2024 and is projected to reach USD 4.7 billion by 2032, growing at a CAGR of 4.66%. 1029
Ovarian cancer can be difficult to detect in its earlier stages because symptoms may be...
Bangla